Fingerprint Drug Test receives FDA Regulatory Pathway Guidance

FDA

Intelligent Fingerprinting, a subsidiary of Intelligent Bio Solutions, has received guidance from the U.S. Food and Drug Administration (FDA) on the regulatory classification of its Drug Screening Cartridge.

The FDA’s preliminary assessment places the Cartridge under 21 CFR 862.3650, Opiate Test System – a Class II device that requires submission of a 510(k) pre-market notification and clearance prior to marketing. This feedback provides a clear regulatory pathway as Intelligent Fingerprinting prepares to expand into the U.S.

A Step Towards U.S. Expansion

Harry Simeonidis, President and CEO of Intelligent Bio Solutions, commented:

“Receiving the FDA’s preliminary assessment is an important milestone as we move towards introducing our technology to the U.S. market. With its portability, speed, and dignified approach, we believe fingerprint drug testing can help U.S. workplaces strengthen their safety programmes while making testing simpler and more efficient.”

About the System

The Intelligent Fingerprinting Drug Screening System detects the presence of specific drugs and/or their metabolites using fingerprint sweat. The process is quick and hygienic, collecting ten fingerprint samples in less than a minute onto a tamper-evident Cartridge. Results are available in ten minutes via the portable analysis unit.

Cartridges are designed to screen for multiple drug groups at once, including opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The system offers employers a non-invasive, dignified, and rapid solution compared with traditional urine or saliva testing methods.

With more than 350 customers internationally, Intelligent Fingerprinting is already helping organisations deter substance misuse in the workplace, supporting employee safety, wellbeing, and compliance with health and safety policies.

Meet The Author

Intelligent Fingerprinting

Intelligent Fingerprinting

Related Articles

Skilled construction worker

Does workplace drug testing affect staff retention? It can. An intrusive, heavy-handed approach to drug testing at work can quietly push good employees towards the door. People do not forget an experience that felt invasive or accusatory, and for a skilled worker with options, that is one more reason to look elsewhere. This article looks…

Fingerprint drug testing during procurement

Do contracts require a drug and alcohol policy? Increasingly, the answer is yes. For a few sectors it is a legal requirement; for many more it has become a commercial one, written into the pre-qualification questionnaires and supply-chain standards that decide who gets shortlisted. Either way, the direction of travel is the same: a documented…

Fingerprint drug testing cartridge

Is workplace drug testing worth it? A fair question. Most organisations weigh the cost of testing against zero: the price of the kits versus doing nothing at all. Counted that way, testing will always look like an expense to contain. But that sum measures only one side of the ledger. It ignores what a well-run…

Book A Demo

See the difference fingerprint drug testing can make in your workplace. Request a personalised demonstration today.